Literature DB >> 16291893

Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.

F A H van der Linden1, J J Kragt, M Klein, H M van der Ploeg, C H Polman, B M J Uitdehaag.   

Abstract

BACKGROUND: There may be difficulties in the use of self report measurements in patients with cognitive impairment or serious mood disturbances which interfere with reliable self assessment, as may be the case in multiple sclerosis (MS). In such cases proxies may provide valuable information. However, before using any questionnaires in a proxy sample, the questionnaire should be evaluated for proxy use.
OBJECTIVE: To evaluate the psychometric properties of the 29 item Multiple Sclerosis Impact Scale (MSIS-29) when used by proxies of MS patients.
METHODS: A sample of 62 partners of MS patients completed the MSIS-29. The data were evaluated for the psychometric criteria of the MSIS-29, including data quality, scaling assumptions, acceptability, reliability, validity, and responsiveness.
RESULTS: Psychometric evaluation was satisfactory; data quality was high, and scaling assumptions and acceptability were good. Reliability was high (alpha>0.80). Findings were consistent with results of a psychometric evaluation in a patient sample.
CONCLUSIONS: The MSIS-29 can be used reliably in proxies of patients with MS. As a next step the relation between data obtained from patients and proxies needs to be studied, focusing on factors that may affect agreement and discrepancies.

Entities:  

Mesh:

Year:  2005        PMID: 16291893      PMCID: PMC1739474          DOI: 10.1136/jnnp.2005.065227

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.

Authors:  G R Norman; P Stratford; G Regehr
Journal:  J Clin Epidemiol       Date:  1997-08       Impact factor: 6.437

Review 2.  General health status measures for people with cognitive impairment: learning disability and acquired brain injury.

Authors:  R P Riemsma; C A Forbes; J M Glanville; A J Eastwood; J Kleijnen
Journal:  Health Technol Assess       Date:  2001       Impact factor: 4.014

3.  Autobiographical memory, depression and quality of life in multiple sclerosis.

Authors:  P M Kenealy; G J Beaumont; T Lintern; R Murrell
Journal:  J Clin Exp Neuropsychol       Date:  2000-02       Impact factor: 2.475

4.  The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis.

Authors:  Yael Goverover; Nancy Chiaravalloti; John DeLuca
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

5.  The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression.

Authors:  Y Maor; L Olmer; B Mozes
Journal:  Mult Scler       Date:  2001-04       Impact factor: 6.312

Review 6.  Self-report measures of patient utility: should we trust them?

Authors:  M Hanita
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

7.  Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.

Authors:  R H B Benedict; F Munschauer; R Linn; C Miller; E Murphy; F Foley; L Jacobs
Journal:  Mult Scler       Date:  2003-02       Impact factor: 6.312

8.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

Review 9.  The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease.

Authors:  Kommer C A Sneeuw; Mirjam A G Sprangers; Neil K Aaronson
Journal:  J Clin Epidemiol       Date:  2002-11       Impact factor: 6.437

10.  Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.

Authors:  A Riazi; J C Hobart; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

View more
  20 in total

1.  Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).

Authors:  V Isella; C Mapelli; N Morielli; D De Gaspari; C Siri; G Pezzoli; A Antonini; M Poletti; U Bonuccelli; L Picchi; A Napolitano; M Vista; M Veglia; F Piamarta; F Grassi; I M Appollonio
Journal:  Funct Neurol       Date:  2013 Apr-May

2.  Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life.

Authors:  F A H van der Linden; J J Kragt; J C Hobart; M Klein; A J Thompson; H M van der Ploeg; C H Polman; B M J Uitdehaag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-04       Impact factor: 10.154

3.  A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach.

Authors:  Pablo Martinez-Martin; Belen Frades-Payo; Luis Agüera-Ortiz; Angel Ayuga-Martinez
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

4.  The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).

Authors:  Lisa Costelloe; Killian O'Rourke; Hugh Kearney; Christopher McGuigan; Lisa Gribbin; Marguerite Duggan; Leslie Daly; Niall Tubridy; Michael Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-01       Impact factor: 10.154

5.  Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?

Authors:  Pablo Martinez-Martin; Marcos Serrano-Dueñas; Maria João Forjaz; Maria Soledad Serrano
Journal:  Qual Life Res       Date:  2007-05-30       Impact factor: 4.147

6.  Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis: A Pilot Study.

Authors:  Sepideh Pooyania; Michelle Lobchuk; Wanda Chernomas; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 May-Jun

7.  The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version.

Authors:  Pablo Martinez-Martin; John B Wetmore; Carmen Rodríguez-Blázquez; Tomoko Arakaki; Oscar Bernal; Victor Campos-Arillo; Christopher Cerda; Ingrid Estrada-Bellmann; Nélida Garretto; Letty Ginsburg; Jorge Uriel Máñez-Miró; Juan Carlos Martínez-Castrillo; Ivonne Pedroso; Marcos Serrano-Dueñas; Carlos Singer; Mayela Rodríguez-Violante; Francisco Vivancos
Journal:  Mov Disord Clin Pract       Date:  2019-03-18

8.  Living with Long term condition Scale: A pilot validation study of a new person centred tool in the UK.

Authors:  Leire Ambrosio; Kelly Hislop-Lennie; Hannah Barker; David Culliford; Mari Carmen Portillo
Journal:  Nurs Open       Date:  2021-03-15

9.  Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning.

Authors:  Javier Virués-Ortega; Jesús de Pedro-Cuesta; Manuel Seijo-Martínez; Pedro Saz; Fernando Sánchez-Sánchez; Fermina Rojo-Pérez; Fernanda Rodríguez; Raimundo Mateos; Pablo Martínez-Martín; Ignacio Mahillo; Jordi Gascon-Bayarri; Josep Garre-Olmo; Francisco Jose García; Gloria Fernández-Mayoralas; Felix Bermejo-Pareja; Alberto Bergareche; Javier Almazan-Isla; Jose Luis del Barrio
Journal:  BMC Public Health       Date:  2011-03-23       Impact factor: 3.295

10.  The physical and psychological impact of multiple sclerosis using the MSIS-29 via the web portal of the UK MS Register.

Authors:  Kerina H Jones; David V Ford; Philip A Jones; Ann John; Rodden M Middleton; Hazel Lockhart-Jones; Jeffrey Peng; Lisa A Osborne; J Gareth Noble
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.